We are heading to Jordan for our first meeting in November! #bmtsm #tcellRx
A Samer Al-Homsi Mohamed Kharfan-Dabaja, MD, MBA Usama Gergis Sherif Farag Amer Beitinjaneh, MD, MSc, MPH, FACP Mohammad Abu Zaid Muna Qayed Rabi Hanna Nora Chokr Razan Mohty Jean Yared Monzr M. AlMalki, MD
Now at UCSF Department of Medicine Grand Rounds Ajai Chari discussing the vexing problem of Parkinsonism arising after BCMA-targeted CAR-T therapies for #myeloma with UCSF Helen Diller Family Comprehensive Cancer Ctr experts including Anupama Kumar characterizing the incidence and prognosis in our large treated population. #Tcellrx
Hello world! 👋
Find below CAR T-cell therapy-related research from our group(s) Fred Hutchinson Cancer Center UW Medicine to be presented at #ASH23 condensed in one 🧵😄
ASH #TcellRx #CARTcells
1/18
At UCSF Department of Medicine Grand Rounds today the leaders of our lymphoma and myeloma programs Babis Andreadis, MD, MSCE and Ajai Chari present the remarkable landscape of #tcellrx in #lymphoma and #myeloma . Here Ajai introducing myeloma.
At UCSF Department of Medicine Grand Rounds Babis Andreadis, MD, MSCE now discussing the unfortunate toxicities of #Tcellrx including the CAR-T toxicities where ASTCT has taken the lead in defining categories of toxicities, also including late cytopenias, hemophagocytic syndromes and Parkinsonism. #lymphoma …
The streak of BMT lectures continue from Dr Lingaraj Nayak sir. Concept building at its best.
#grateful #gurukul #leukemia #oncology #ALL #TcellRx #ismpo
ISMPO Prashant Mehta Saphalta Pmis001 Amrita Hospital, Faridabad Tata Memorial Hospital
manalikamdar Adam Olszewski MD Michael Wang, MD Dr. manalikamdar is also featured in several oral presentations on #celltherapy in #lymsm , including liso-cel in follicular lymphoma as well as MCL, and the prognostic implications of ctDNA from the TRANSFORM trial. #tcellrx #ASH23
Our lymphoma faculty CU Anschutz Division of Hematology had several manuscripts published concurrently with ASH #ASH23 !
First, Drs. Ajay Major, MD, MBA & manalikamdar published an ASH Education manuscript on bispecific antibodies vs CAR-T in relapsed LBCL. #lymsm #tcellrx /1
pubmed.ncbi.nlm.nih.gov/38066907/
The history of leukemia!
It has changed a lot of minds today about how we treat leukemia. Very Insightful Dr Rishi Dhawan ऋषि धवन Sir.
#ismpo #grateful #gurukul #leukemia #oncology #ALL #TcellRx Prashant Mehta ISMPO 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Faheema Hasan 🩸 🩺 Saphalta Pmis001
I'm Extremely Proud And Honoured To Be Part Of This Mission.
Making High-Quality Advanced Cancer Therapy at Affordable Cost #India & Beyond
#cartcelltherapy #cancer CAR-T #cellandgenetherapy #TcellRx #personalizedmedicine #cGMP #cellRx
prnewswire.com/news-releases/…
Congratulations to Dr. Nora Chokr Nora Chokr on completing her advanced fellowship in #bmtsm / #TcellRx
Weill Cornell BMT Program.
We are super proud of you and very happy that you are joining our team! @WeillCornell NewYork-Presbyterian Sam Yamshon Dr. Tsiporah Shore Sebastian mayer Anna Alperovich
Varnimcabtagene autoleucel, an academic anti-CD19 CAR T cell (ARI-0001), shows efficacy in relapsed/refractory B-cell lymphoma
onlinelibrary.wiley.com/doi/10.1111/bj…
#lymsm #TCellRx #ASH23
Julio Delgado Manel Juan Otero Valentín Ortiz-Maldonado Pablo Mozas SoniaGuedan Carlos Fernandez de Larrea
🔥Hot question in B-cell Non-Hodgkins lymphoma: #BMT versus #CART
Mohamed Kharfan-Dabaja, MD, MBA Mayo Clinic Comprehensive Cancer Center (BMT) 💉🆚 Tania Jain Johns Hopkins Medicine (CAR-T) 🧬 Which side are you on?
MayoRegMed Mayo Clinic Hematology-Oncology Fellowship
#bmtsm #mmsm #lymsm #leuksm #TcellRx
Allison Betof Warner, MD, PhD highlighting work by Adam J. Schoenfeld at Memorial Sloan Kettering Cancer Center showing early potential for experimental #TIL therapy for NSC #lungcancer .
Early days—lots of opportunity to improve strategies to better approach results of #tcellrx in blood cancers.
Mira este debate exclusivo grabado en #iwMyeloma23 entre Jesús San Miguel, Paula Rodriguez-Otero, Carlos Fernandez de Larrea y Enrique M Ocio sobre los últimos avances en #mieloma .
👉ow.ly/MJ8F50NyTsK👈
#HemOnc #MielomaMúltiple #MMsm #ImmunoOnc #tcellrx #CART